RenovoRx (NASDAQ: RNXT) , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath(R), a novel, FDA-cleare ...

Most investigators have usually relied upon bilateral carotid arteriography in combination with bilateral subclavian or retrograde injection into the brachial arteries. These technics were used in ...

However, potential hemodynamic mechanisms underlying independent predictors for postinterventional rupture of IAs remain unclear. In this study, we employed arteriography-derived radiomic features to ...